The Food and Drug Administration’s Center for Veterinary Medicine has issued an urgent warning about Librela, a widely-used injectable medication for dogs with osteoarthritis, following reports of severe adverse effects including deaths. Between January 2023 and March 2024, over 3,600 cases of adverse reactions were documented, ranging from neurological complications to fatalities. Most reports were submitted by veterinarians and other healthcare professionals. The FDA’s evaluation revealed concerning side effects such as ataxia (loss of muscle control), seizures, partial paralysis, and urinary problems. “In some cases, death (including euthanasia) was reported as an outcome of these adverse events,” the FDA stated … Continue reading FDA Warns: Librela Linked to 3,600+ Adverse Reactions, Including Seizures and Deaths in Dogs